As of August 22, 2022, over 80 percent of adults in Western Australia had been vaccinated with three doses of a COVID-19 vaccine. In comparison, less than 60 percent of Queensland population aged 16 years and over and received three doses of a COVID-19 vaccine.

The number of COVID-19 vaccination doses administered per 100 people in Australia rose to 243 as of Oct 27 2023. This dataset includes a chart with historical data for Australia Coronavirus Vaccination Rate.

In 2021, a survey conducted in Australia about COVID-19 vaccinations reported that about ** percent of respondents in Australia who took part in the survey were hesitant on taking the vaccine because they worried about the side effects of the vaccines or thought the vaccines were unsafe. That same year, about ** percent of respondents in Australia said they were not willing to take the COVID-19 vaccine.

This dataset provides values for CORONAVIRUS VACCINATION RATE reported in several countries. The data includes current values, previous releases, historical highs and record lows, release frequency, reported unit and currency.

As of August 22, 2022, around 68.8 percent of Australians aged over 16 had received a coronavirus booster vaccine or third dose. At the beginning of the year, hundreds of thousands of booster shots were being administered daily. As 2022 progressed, the number of daily booster shots gradually trended downward as the share of Australians who had received a booster shot increased.

The dataset contains vaccination data for the country Australia.

Column Details: 1. Date: This field contains dates starting from 9th April 2021 to 6th Jan 2023 2. 1st Dose: This field contains the total number of populations, who received the 1st Dose. 3. Percentage Of Population Covered by 1st Dose: This field contains the total percentage of the total population who received the first dose. 4. 2nd Dose: This field contains the total number of populations, who received the 2nd Dose. 5. Booster: This field contains the total number of populations, who received Booster. 6. 4th Dose: This field contains the total number of populations, who received the 4th Dose.

Data is extracted from: https://covidlive.com.au/

The average for 2022 based on 12 countries was 83 percent. The highest value was in Fiji: 99 percent and the lowest value was in Papua New Guinea: 36 percent. The indicator is available from 1980 to 2022. Below is a chart for all countries where data are available.

Time series data for the statistic Immunization, measles (% of children ages 12-23 months) and country Australia. Indicator Definition:Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.The indicator "Immunization, measles (% of children ages 12-23 months)" stands at 91.00 as of 12/31/2024. Regarding the One-Year-Change of the series, the current value is equal to the value the year prior.The 1 year change in percent is 0.0.The 3 year change in percent is -2.15.The 5 year change in percent is -3.19.The 10 year change in percent is -3.19.The Serie's long term average value is 88.14. It's latest available value, on 12/31/2024, is 3.24 percent higher, compared to it's long term average value.The Serie's change in percent from it's minimum value, on 12/31/1983, to it's latest available value, on 12/31/2024, is +33.82%.The Serie's change in percent from it's maximum value, on 12/31/2022, to it's latest available value, on 12/31/2024, is -5.21%.

Invasive meningococcal disease is a life-threatening infection preventable through vaccination. Pediatric vaccination rates have declined during the coronavirus disease 2019 (COVID-19) pandemic. This survey aimed to understand how parents’ attitudes and behaviors have changed during the pandemic with regard to immunization and, more specifically, meningococcal vaccination. An online survey was emailed to parents of eligible children 0–4 years, following the selection process from UK, France, Germany, Italy, Brazil, Argentina, and Australia; and of adolescents 11–18 years from US. Data collection took place 19 January–16 February 2021. Quotas were set to ensure a representative sample. Eleven questions relating to general perceptions around vaccination and attitudes and behaviors toward meningitis vaccination were displayed. On 4,962 parents (average 35 years) participating in the survey, most (83%) believed important for their child to continue receiving recommended vaccines during the COVID-19 pandemic. Nearly half of routine vaccine appointments were delayed or canceled due to the pandemic, and 61% of respondents were likely to have their children catch up once COVID-19 restrictions were lifted. 30% of meningitidis vaccination appointments were canceled or delayed during the pandemic, and 21% of parents did not intend to reschedule them because of lockdown/stay at home regulations, and fear of catching COVID-19 in public places. It is crucial to communicate clear instructions to health workers and the general population and to provide appropriate safety precautions in vaccination centers. This will help to maintain vaccination rates and limit infections to prevent future outbreaks. What is the context?Invasive meningococcal disease (IMD) is an uncommon infection that can lead to permanent disabilities and even death.Meningitis vaccination can prevent IMDs caused by Neisseria meningitidis.Vaccination rates have declined during the coronavirus (COVID-19) pandemic. Invasive meningococcal disease (IMD) is an uncommon infection that can lead to permanent disabilities and even death. Meningitis vaccination can prevent IMDs caused by Neisseria meningitidis. Vaccination rates have declined during the coronavirus (COVID-19) pandemic. What is new?We collected opinion of parents from the UK, France, Germany, Italy, Brazil, Argentina, Australia, and the US, to understand their attitudes and behaviors toward meningitis vaccination during the COVID-19 pandemic.Results were reviewed by health care professional experts as well as by patient authors (IMD survivors).Most (83%) of the 4,962 parents believed that it is important for their child to continue receiving recommended vaccines during the COVID-19 pandemic.Half of the scheduled appointments for meningitis vaccination were canceled or delayed during the COVID-19 pandemic, mainly due to lockdown regulations and fear of catching COVID-19.Twenty-one percent of the parents who had their child’s meningitis vaccination appointment canceled, did not intend to reschedule it. We collected opinion of parents from the UK, France, Germany, Italy, Brazil, Argentina, Australia, and the US, to understand their attitudes and behaviors toward meningitis vaccination during the COVID-19 pandemic. Results were reviewed by health care professional experts as well as by patient authors (IMD survivors). Most (83%) of the 4,962 parents believed that it is important for their child to continue receiving recommended vaccines during the COVID-19 pandemic. Half of the scheduled appointments for meningitis vaccination were canceled or delayed during the COVID-19 pandemic, mainly due to lockdown regulations and fear of catching COVID-19. Twenty-one percent of the parents who had their child’s meningitis vaccination appointment canceled, did not intend to reschedule it. What is the impact?It is crucial that clear information is communicated by health care authorities and practitioners about the availability of vaccination during pandemic and the safety precautions that are taken.Collected opinions emphasize the importance of continuing vaccinations against infectious diseases during a pandemic. It is crucial that clear information is communicated by health care authorities and practitioners about the availability of vaccination during pandemic and the safety precautions that are taken. Collected opinions emphasize the importance of continuing vaccinations against infectious diseases during a pandemic.

The average for 2022 based on 12 countries was 84 percent. The highest value was in Fiji: 99 percent and the lowest value was in Papua New Guinea: 44 percent. The indicator is available from 1980 to 2022. Below is a chart for all countries where data are available.

Context

The COVID-19 outbreak has brought the whole planet to its knees.More over 4.5 million people have died since the writing of this notebook, and the only acceptable way out of the disaster is to vaccinate all parts of society. Despite the fact that the benefits of vaccination have been proved to the world many times, anti-vaccine groups are springing up all over the world. This data set was generated to investigate the impact of coronavirus vaccinations on coronavirus mortality.

Content

Data Collection

This dataset is a combination of the following three datasets:

1.https://www.kaggle.com/gpreda/covid-world-vaccination-progress

2.https://covid19.who.int/WHO-COVID-19-global-data.csv

3.https://www.kaggle.com/rsrishav/world-population

you can find more detail about this dataset by reading this notebook:

https://www.kaggle.com/sinakaraji/simple-linear-regression-covid-vaccination

Countries in this dataset:

Frequency of correct responses presented.

Factors associated with receipt of the HPV vaccine between 2007 and 2009 as part of the National HPV Vaccination Program among 417 female participants living in Victoria, Australia, overall and stratified by age-group at commencement of the HPV vaccination program.

This dataset presents the footprint of the percentage of boys who were fully immunised against human papillomavirus (HPV). The data spans the financial years 2014-2016 and is aggregated to …Show full descriptionThis dataset presents the footprint of the percentage of boys who were fully immunised against human papillomavirus (HPV). The data spans the financial years 2014-2016 and is aggregated to Statistical Area Level 4 (SA4) geographic boundaries from the 2011 Australian Statistical Geography Standard (ASGS). HPV is a common sexually transmitted infection. It is estimated that more than four out of five people will have an HPV infection at some point in their lives. Although often asymptomatic, HPV infection can cause a wide range of cancers, including cervical cancer, and other conditions such as genital warts. The Australian Government introduced the school-based National HPV Vaccination Program in 2007 for adolescent girls, and extended it to include boys in January 2013. The data were sourced from the National HPV Vaccination Program Register (HPV Register), which is operated by the Victorian Cytology Service. The HPV Register records information about HPV vaccine doses administered under the National HPV Vaccination Program in Australia. The data reported are for girls and boys aged 15 who had received three doses of HPV vaccine by 30 June 2016 (as at 12 August 2017). The Australian Bureau of Statistics (ABS) Estimated Resident Population (ERP) for females and males aged 13 at 30 June 2014 was used for the denominator, as this reflects the eligible population at the time most vaccinations were administered. For further information about this dataset, visit the data source: Australian Institute of Health and Welfare - HPV immunisation rates in 2015-16 Data Tables. Please note: AURIN has spatially enabled the original data. These data include boys aged 15 who had received three doses of HPV vaccine by 30 June 2015 and 2016. Any doses administered after that date are not included and therefore the current coverage in this cohort may be higher than reported here. Only vaccinations reported to the National HPV Vaccination Program Register (HPV Register) are included. Boys whose courses are considered to be incomplete according to the Chief Medical Officer guidelines and boys who do not wish their details to be recorded on the HPV Register are excluded. Copyright attribution: Government of the Commonwealth of Australia - Australian Institute of Health and Welfare, (2017): ; accessed from AURIN on 12/3/2020. Licence type: Creative Commons Attribution 3.0 Australia (CC BY 3.0 AU)

This dataset presents the footprint of the percentage of girls who were fully immunised against human papillomavirus (HPV). The data spans the financial years 2012-2016 and is aggregated to Statistical Area Level 4 (SA4) from the 2011 Australian Statistical Geography Standard (ASGS).

HPV is a common sexually transmitted infection. It is estimated that more than four out of five people will have an HPV infection at some point in their lives. Although often asymptomatic, HPV infection can cause a wide range of cancers, including cervical cancer, and other conditions such as genital warts. The Australian Government introduced the school-based National HPV Vaccination Program in 2007 for adolescent girls, and extended it to include boys in January 2013. The data were sourced from the National HPV Vaccination Program Register (HPV Register), which is operated by the Victorian Cytology Service. The HPV Register records information about HPV vaccine doses administered under the National HPV Vaccination Program in Australia. The data reported are for girls and boys aged 15 who had received three doses of HPV vaccine by 30 June 2016 (as at 12 August 2017). The Australian Bureau of Statistics (ABS) Estimated Resident Population (ERP) for females and males aged 13 at 30 June 2014 was used for the denominator, as this reflects the eligible population at the time most vaccinations were administered.

\t\t\t\t\t\t\t\t\t\t\t\t\tFor further information about this dataset, visit the data source:Australian Institute of Health and Welfare - HPV immunisation rates in 2015-16 Data Tables.

Please note:

• AURIN has spatially enabled the original data using the Department of Health - PHN Areas.

• These data include girls aged 15 who had received three doses of HPV vaccine by 30 June 2013, 2014, 2015 and 2016. Any doses administered after that date are not included and therefore the current coverage in this cohort may be higher than reported here. Only vaccinations reported to the National HPV Vaccination Program Register (HPV Register) are included.

• Girls whose courses are considered to be incomplete according to the Chief Medical Officer guidelines and girls who do not wish their details to be recorded on the HPV Register are excluded.

• Values assigned to "n.p." in the original data have been removed from the data.

Objectives This study evaluated the uptake of Western Australian (WA) pharmacist vaccination services, the profiles of consumers being vaccinated and the facilitators and challenges experienced by pharmacy staff in the preparation, implementation and delivery of services. Design Mixed-methods methodology with both quantitative and qualitative data through surveys, pharmacy computer records and immuniser pharmacist interviews. Setting Community pharmacies in WA that provided pharmacist vaccination services between March and October 2015. Participants Immuniser pharmacists from 86 pharmacies completed baseline surveys and 78 completed exit surveys; computer records from 57 pharmacies; 25 immuniser pharmacists were interviewed. Main outcome measures Pharmacy and immuniser pharmacist profiles; pharmacist vaccination services provided and consumer profiles who accessed services. Results 15 621 influenza vaccinations were administered by immuniser pharmacists at 76 WA community pharmacies between March and October 2015. There were no major adverse events, and <1% of consumers experienced minor events which were appropriately managed. Between 12% and 17% of consumers were eligible to receive free influenza vaccinations under the National Immunisation Program but chose to have it at a pharmacy. A high percentage of vaccinations was delivered in rural and regional areas indicating that provision of pharmacist vaccination services facilitated access for rural and remote consumers. Immuniser pharmacists reported feeling confident in providing vaccination services and were of the opinion that services should be expanded to other vaccinations. Pharmacists also reported significant professional satisfaction in providing the service. All participating pharmacies intended to continue providing influenza vaccinations in 2016. Conclusions This initial evaluation of WA pharmacist vaccination services showed that vaccine delivery was safe. Convenience and accessibility were important aspects in usage of services. There is scope to expand pharmacist vaccination services to other vaccines and younger children; however, government funding to pharmacists needs to be considered.

Demographic, lifestyle and sexual behaviour characteristics among 417 participants who were offered HPV vaccination between 2007 and 2009 as part of the National HPV Vaccination Program, living in Victoria, by NHVPR confirmed vaccination status.

Australia Immunization: HepB3: % of One-Year-Old Children data was reported at 94.000 % in 2023. This stayed constant from the previous number of 94.000 % for 2022. Australia Immunization: HepB3: % of One-Year-Old Children data is updated yearly, averaging 94.000 % from Dec 2001 (Median) to 2023, with 23 observations. The data reached an all-time high of 95.000 % in 2021 and a record low of 91.000 % in 2014. Australia Immunization: HepB3: % of One-Year-Old Children data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Australia – Table AU.World Bank.WDI: Social: Health Statistics. Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.;WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).;Weighted average;

Actual value and historical data chart for Australia Immunization Dpt Percent Of Children Ages 12 23 Months

As of September 2021, around 62 percent of adults in Australia aged 18 to 34 years who wanted a vaccination against COVID-19 had received one, which is a much lower rate than in Canada where 95 percent of adults who wanted a vaccination had already had one. This statistic illustrates the percentage of adults aged 18 to 34 years who had been vaccinated against COVID-19 among those who wanted to get vaccinated worldwide as of September 2021, by country.